Melissa Jane Davis

Melissa Jane Davis

Auto-generated profile, based on publicly available information

Melissa Jane Davis

Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MFMomeneh Foroutan
Momeneh Foroutan
DBDharmesh D. Bhuva
Dharmesh D. Bhuva
RLRuqian Lyu
Ruqian Lyu
KHKristy Horan
Kristy Horan
JCJoseph Cursons
Joseph Cursons
MDMelissa J. Davis
Melissa J. Davis
Gene set scoring provides a useful approach for quantifying concordance between sample transcriptomes and selected molecular signatures. Most methods use information from all samples to score an individual sample, leading to unstable scores in small data sets and introducing biases from sample composition (e.g. varying numbers of samples for different cancer subtypes). To address these issues, we have developed a truly single sample scoring method, and associated R/Bioconductor package singscore ( https://bioconductor.org/packages/singscore ). We use multiple cancer data sets to compare singscore against widely-used methods, including GSVA, z-score, PLAGE, and ssGSEA. Our approach does not depend upon background samples and scores are thus stable regardless of the composition and number of samples being scored. In contrast, scores obtained by GSVA, z-score, PLAGE and ssGSEA can be unstable when less data are available (NS < 25). The singscore method performs as well as the best performing methods in terms of power, recall, false positive rate and computational time, and provides consistently high and balanced performance across all these criteria. To enhance the impact and utility of our method, we have also included a set of functions implementing visual analysis and diagnostics to support the exploration of molecular phenotypes in single samples and across populations of data. The singscore method described here functions independent of sample composition in gene expression data and thus it provides stable scores, which are particularly useful for small data sets or data integration. Singscore performs well across all performance criteria, and includes a suite of powerful visualization functions to assist in the interpretation of results. This method performs as well as or better than other scoring approaches in terms of its power to distinguish samples with distinct biology and its ability to call true differential gene sets between two conditions. These scores can be used for dimensional reduction of transcriptomic data and the phenotypic landscapes obtained by scoring samples against multiple molecular signatures may provide insights for sample stratification.

1 July 2019 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
JCJoseph Cursons
Joseph Cursons
Fernando Souza-Fonseca-GuimaraesFernando Souza-Fonseca-Guimaraes
Fernando Souza-Fonseca-Guimaraes
MFMomeneh Foroutan
Momeneh Foroutan
AAAshley Anderson
Ashley Anderson
Frederic HollandeFrederic Hollande
Frederic Hollande
MDMelissa J. Davis
Melissa J. Davis
Natural killer (NK) cell activity is essential for initiating antitumor responses and may be linked to immunotherapy success. NK cells and other innate immune components could be exploitable for cancer treatment, which drives the need for tools and methods that identify therapeutic avenues. Here, we extend our gene-set scoring method singscore to investigate NK cell infiltration by applying RNA-seq analysis to samples from bulk tumors. Computational methods have been developed for the deconvolution of immune cell types within solid tumors. We have taken the NK cell gene signatures from several such tools, then curated the gene list using a comparative analysis of tumors and immune cell types. Using a gene-set scoring method to investigate RNA-seq data from The Cancer Genome Atlas (TCGA), we show that patients with metastatic cutaneous melanoma have an improved survival rate if their tumor shows evidence of NK cell infiltration. Furthermore, these survival effects are enhanced in tumors that show higher expression of genes that encode NK cell stimuli such as the cytokine IL15. Using this signature, we then examine transcriptomic data to identify tumor and stromal components that may influence the penetrance of NK cells into solid tumors. Our results provide evidence that NK cells play a role in the regulation of human tumors and highlight potential survival effects associated with increased NK cell activity. Our computational analysis identifies putative gene targets that may be of therapeutic value for boosting NK cell antitumor immunity.

7 June 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
NJNicolas Jacquelot
Nicolas Jacquelot
CSCyril Seillet
Cyril Seillet
MWMinyu Wang
Minyu Wang
APAngela Pizzolla
Angela Pizzolla
YLYang Liao
Yang Liao
GBGabrielle T. Belz
Gabrielle T. Belz

1 July 2018 in Cell Systems
Verified
Journal Article
Open access
JCJoseph Cursons
Joseph Cursons
KPKatherine A. Pillman
Katherine A. Pillman
KSKaitlin G. Scheer
Kaitlin G. Scheer
Philip GregoryPhilip Gregory
Philip Gregory
MFMomeneh Foroutan
Momeneh Foroutan
MDMelissa J. Davis
Melissa J. Davis
MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression, functioning in part by facilitating the degradation of target mRNAs. They have an established role in controlling epithelial-mesenchymal transition (EMT), a reversible phenotypic program underlying normal and pathological processes. Many studies demonstrate the role of individual miRNAs using overexpression at levels greatly exceeding physiological abundance. This can influence transcripts with relatively poor targeting and may in part explain why over 130 different miRNAs are directly implicated as EMT regulators. Analyzing a human mammary cell model of EMT we found evidence that a set of miRNAs, including the miR-200 and miR-182/183 family members, co-operate in post-transcriptional regulation, both reinforcing and buffering transcriptional output. Investigating this, we demonstrate that combinatorial treatment altered cellular phenotype with miRNA concentrations much closer to endogenous levels and with less off-target effects. This suggests that co-operative targeting by miRNAs is important for their physiological function and future work classifying miRNAs should consider such combinatorial effects.

25 February 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CLCynthia Louis
Cynthia Louis
Fernando Souza-Fonseca-GuimaraesFernando Souza-Fonseca-Guimaraes
Fernando Souza-Fonseca-Guimaraes
YYYuyan Yang
Yuyan Yang
DDDamian D’sIlva
Damian D’sIlva
TKTobias Kratina
Tobias Kratina
IWIan P. Wicks
Ian P. Wicks
Despite increasing recognition of the importance of GM-CSF in autoimmune disease, it remains unclear how GM-CSF is regulated at sites of tissue inflammation. Using GM-CSF fate reporter mice, we show that synovial NK cells produce GM-CSF in autoantibody-mediated inflammatory arthritis. Synovial NK cells promote a neutrophilic inflammatory cell infiltrate, and persistent arthritis, via GM-CSF production, as deletion of NK cells, or specific ablation of GM-CSF production in NK cells, abrogated disease. Synovial NK cell production of GM-CSF is IL-18–dependent. Furthermore, we show that cytokine-inducible SH2-containing protein (CIS) is crucial in limiting GM-CSF signaling not only during inflammatory arthritis but also in experimental allergic encephalomyelitis (EAE), a murine model of multiple sclerosis. Thus, a cellular cascade of synovial macrophages, NK cells, and neutrophils mediates persistent joint inflammation via production of IL-18 and GM-CSF. Endogenous CIS provides a key brake on signaling through the GM-CSF receptor. These findings shed new light on GM-CSF biology in sterile tissue inflammation and identify several potential therapeutic targets.

30 September 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DBDharmesh D Bhuva
Dharmesh D Bhuva
JCJoseph Cursons
Joseph Cursons
MDMelissa J Davis
Melissa J Davis
Gene expression signatures have been critical in defining the molecular phenotypes of cells, tissues, and patient samples. Their most notable and widespread clinical application is stratification of breast cancer patients into molecular (PAM50) subtypes. The cost and relatively large amounts of fresh starting material required for whole-transcriptome sequencing has limited clinical application of thousands of existing gene signatures captured in repositories such as the Molecular Signature Database. We identified genes with stable expression across a range of abundances, and with a preserved relative ordering across thousands of samples, allowing signature scoring and supporting general data normalisation for transcriptomic data. Our new method, stingscore, quantifies and summarises relative expression levels of signature genes from individual samples through the inclusion of these ‘stably-expressed genes’. We show that our list of stable genes has better stability across cancer and normal tissue data than previously proposed gene sets. Additionally, we show that signature scores computed from targeted transcript measurements using stingscore can predict docetaxel response in breast cancer patients. This new approach to gene expression signature analysis will facilitate the development of panel-type tests for gene expression signatures, thus supporting clinical translation of the powerful insights gained from cancer transcriptomic studies.